Israel prepared to keep clinical trials running during war

Clinical trial operations will continue in Israel during the declared war, due to preparations in place by the Ministry of Health (IMOH), a CEO of a drug development company has said.

Mati Gill, CEO of AION labs based in Tel Aviv, an innovation lab for artificial intelligence in drug discovery and development that works with sponsors including AstraZeneca, Pfizer and Merck, said that due to the country having contingency plans in place, it will be able to continue all clinical trial operations during the war.